Aspirin in stroke patients modifies the immunomodulatory interactions of marrow stromal cells and monocytes.

CONCLUSIONS: Aspirin in acute stroke patients may modulate the secretome profile of Mo and MSCs, thus potentially modulating immune and inflammatory responses associated with stroke. Our results suggest that stroke trials involving the use of intravenous MSCs should consider the effect of aspirin as a confounding factor. PMID: 31220426 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31220426?dopt=Abstract

Source: Brain Research - June 16, 2019 Category: Neurology Authors: Satani N, Giridhar K, Cai C, Wewior N, Norris DD, Olson SD, Aronowski J, Savitz SI Tags: Brain Res Source Type: research